confirmatory testing of naats should be routine for chlamydia infections in populations with < 4%...

24
Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University of Pittsburgh School of Medicine Magee-Womens Hospital

Upload: kyler-harms

Post on 14-Dec-2015

218 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence

Harold C. Wiesenfeld, M.D.,C.M.

University of Pittsburgh School of Medicine

Magee-Womens Hospital

Page 2: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Positive Predictive Value:The Influence of Disease Prevalence

Zenilman. Sex Transm Infect 2003

Page 3: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Positive Predictive Value:The Influence of Disease Prevalence

PPV at Specificity of:

Prevalence 98% 99% 99.5%

10% 84% 91% 95%

5% 71% 83% 90%

2% 49% 66% 79%

1% 32% 49% 66%

0.5% 19% 32% 49%

Page 4: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Positive Predictive Value:The Influence of Disease Prevalence

95% Sensitivity 99% Specificity

Prevalence Test True Infection PPV

+ -

10% + 95 9 104 91%

- 5 891 896 (95/104)

100 900 1000

4% + 38 10 48 79%

- 2 950 952 (38/48)

40 960 1000

2% + 19 10 29 66%

- 1 970 971 (19/29)

20 980 1000

Page 5: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

BD ProbeTec PerformanceMulticenter Evaluation

Female Swab Male Swab

Lab Prevalence SPEC PPV SPEC PPV

IU 13.4% 95.7 76.8 96.1 86.8

JHU 9.0% 99.0 87.4 98.1 92.1

UCSF 5.3% 100 100 100 100

SJPHS 4.4% 99.2 84.6 - -

UAB 15.1% 98.6 92.1 95.2 86.3

UMMS 10.9% 98.6 77.7 80.0 50

CCF 11.5% 95.7 75.1 - -

Van Der Pol et al. J Clin Micro 2001

Page 6: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

LCR PerformanceMulticenter Evaluation

Female Swab Male Urine

Lab Prevalence SPEC PPV SPEC PPV

IU 13.4% 98.8 92.5 97.0 89

JHU 9.0% 99.0 85.6 96.2 85.4

UCSF 5.3% 100 100 100 100

SJPHS 4.4% 99.4 88.5 - -

UAB 15.1% 99.3 95.9 95.2 97.3

UMMS 10.9% 98.5 89.1 80.0 66.7

CCF 11.5% 100 100 - -

Van Der Pol et al. J Clin Micro 2001

Page 7: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Reproducibility of BD Probe-Tec

Initial MOTA Scores

2,000-9,999 >10,000

Repeat Positive

21 175

Repeat Negative

5 6

Total 26 181

Culler. J Clin Micro 2003

Page 8: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a Positive CT Test

• Psychosocial Impact/Stigma

• Negative impact on sexual relationships

• Future Reproductive Morbidity

• Cost

• Resource Utilization

Page 9: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a Positive CT Test

• Psychosocial Impact– Shock– Depression– Anxiety– Guilt– Isolation– Shame– Stigma (?barrier to future STD care?)

Page 10: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a Positive CT Test

• Negative impact on sexual relationships– Destroyed relationships– Accusations of infidelity– Impaired intimacy– Less sexually desirable– Less sexual enjoyment

Page 11: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a Positive CT Test

• Future Reproductive Morbidity– Increased risk of

• Ectopic pregnancy• Tubal factor infertility• Chronic pelvic pain

– Neonatal transmission

Page 12: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a False-Positive CT TestShort-Term Costs

Confirmatory Testing

Additional assay• Small # of specimens in

low prev. populations

• Lab issues

No Confirmatory Testing

TreatmentPartner notificationPartner treatmentScreening for other STDsCounseling time

Page 13: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a Positive CT TestLong-Term Costs

Resource Utilization

• False positive tests will lead to increased utilization of healthcare services ($$$)– Repeat screening for C. trachomatis

• Follow national screening recommendations

– Increased healthcare utilization• Patient is “labelled”• All pelvic pain = PID (costs of treatment)• Increased surveillance for ectopic pregnancy

Page 14: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Implications of a False-Positive CT TestOverall Costs

Confirmatory Testing

Additional assay

No Confirmatory Testing

TreatmentPartner notificationPartner treatmentScreening for other STDsCounseling timeRepeat testingFuture testing and work-up for

possible STD-related illness (e.g. PID, ectopic pregnancy)

Reduce costs

Page 15: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Is Educating Physicians on the Proper Interpretation

of STD Tests a

Viable Strategy?

Page 16: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Will Providers Properly Counsel Patients?

• 71% of PA primary care physicians report adequate STD training in residency (Ashton, Cook, Wiesenfeld et al. Sex Transm Dis 2002)

• 38% of adults were asked about STDs during routine checkups in the last year (Tao, Irwin & Kasler Am J Prev Med 2000)

• Only 32% of primary care physicians report screening a sexually active teen for CT (Cook, Wiesenfeld, Ashton et al. J Adol Health 2001)

• Only 61% of PCPs met criteria for adequate STD knowledge (Wiesenfeld, Cook et al. Unpublished data)

QUALITY OF STD CARE VARIES AND IS IMPERFECT

Page 17: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

“Clinicians must know the approximate prevalence of the condition of interest in the population being tested; if not, reasonable interpretation is impossible”

David A. Grimes & Kenneth F. Shulz

Uses and Abuses of Screening Tests

Lancet 2002

Page 18: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

What do the Providers Know About False Positive STD Tests?

• NOT MUCH!• Survey of local providers:

– 94% underestimated the false-positive rate of a NAAT CT test in a low prevalence population

– Most physicians vastly underestimated the false positive rate of CT NAAT testing:• Two-thirds estimated the false positive rate of

< 5% in a population where the risk of a positive test being a false positive is 50%

Page 19: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Do Physicians Currently Follow Recommendations Concerning False-Positive Tests?

CDC (MMWR Oct 18, 2002):

“Patients with positive screening test results require counseling regarding…the possibility of a false-positive result”

Survey:

76% of physicians rarely (<1%) inform patients with a positive CT NAAT result that it may be a false positive

Page 20: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Do Physicians Currently Follow Recommendations Concerning False-Positive Tests?

CDC (MMWR Oct 18, 2002):

“Because therapy for CT is safe and should not be delayed, therapy can be offered while awaiting additional test results…”

Survey:

18% of physicians would offer empiric treatment before or in lieu of retesting

Page 21: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Is Educating Physicians on the Proper Interpretation

of STD Tests a

Viable Strategy?

Doubtful

Page 22: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University
Page 23: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

Should Confirmatory Testing of NAATs be Routine for Chlamydia Infections in Populations

with < 4% Prevalence?

YES• Not labor intensive• Additional costs small (small #s)• Reduction in costs incurred with false-positive

tests (short and long-term)• Eliminate unnecessary adverse psychosocial

impact• Feasibility of providers incorporating counseling

on false-positive results is questionable• Improved quality of care for our patients

Page 24: Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University

“ Remember: a clinician, not a laboratory test, makes a diagnosis. Overinterpretation of test results is the first cost of molecular diagnostics”

Jeffrey Klausner, MD

Clin Infect Dis 2004